Answers are grounded in this paper and cite their sources.
Adenoviral vectors are under investigation for a broad range of therapeutic indications in diverse fields, such as oncology and gene therapy, as well as for vaccination both for human and veterinary use. A wealth of data shows that preexisting immune responses may limit the use of a vector.
No takes yet. Share an insight, caveat, or question.
Ballmann et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: